INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $294 | -20.8% | 9,312 | +2.4% | 0.00% | 0.0% |
| Q2 2023 | $371 | -7.7% | 9,093 | -15.7% | 0.00% | 0.0% |
| Q1 2023 | $402 | -12.2% | 10,781 | -17.9% | 0.00% | -25.0% |
| Q4 2022 | $458 | -99.9% | 13,125 | +15.6% | 0.00% | -33.3% |
| Q3 2022 | $635,000 | +10.2% | 11,352 | +2.0% | 0.01% | +20.0% |
| Q2 2022 | $576,000 | -30.6% | 11,130 | -2.5% | 0.01% | -16.7% |
| Q1 2022 | $830,000 | -71.4% | 11,420 | -53.5% | 0.01% | -45.5% |
| Q4 2021 | $2,902,000 | +76.6% | 24,550 | +100.5% | 0.01% | -21.4% |
| Q3 2021 | $1,643,000 | -15.9% | 12,245 | +1.5% | 0.01% | -12.5% |
| Q2 2021 | $1,953,000 | +211.5% | 12,063 | +54.5% | 0.02% | -33.3% |
| Q1 2021 | $627,000 | +47.2% | 7,810 | -0.3% | 0.02% | +50.0% |
| Q4 2020 | $426,000 | – | 7,835 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Associates IX, LLC | 1,113,376 | $89,359,000 | 15.01% |
| Burrage Capital Management LLC | 63,634 | $5,107,000 | 4.14% |
| Integral Health Asset Management, LLC | 170,000 | $13,643,000 | 3.90% |
| Ally Bridge Group (NY) LLC | 225,000 | $18,057,000 | 3.46% |
| Elmwood Wealth Management, Inc. | 67,174 | $5,391,000 | 3.29% |
| Nikko Asset Management Americas, Inc. | 4,843,270 | $388,697,000 | 1.90% |
| ARK Investment Management | 9,611,911 | $771,404,000 | 1.53% |
| Spectrum Planning & Advisory Services Inc. | 18,521 | $1,486,000 | 1.53% |
| Lombard Odier Asset Management (Switzerland) SA | 282,953 | $22,708,000 | 1.51% |
| Intellectus Partners, LLC | 71,625 | $4,606,000 | 1.26% |